Form 4 Filing for Axogen, Inc. - Officer/Director Transaction

This SEC filing details a Form 4 transaction by Joseph A. Tyndall, a director at Axogen, Inc. On June 19, 2026, Mr. Tyndall acquired 14,150 shares of Common Stock and 14,150 Restricted Stock Units (RSUs). The acquisition of Common Stock, valued at $0 per share, is noted as an annual equity grant for his service as a Director. The RSUs also represent a contingent right to receive one share of Common Stock each and were granted with a valuation of $150,000, vesting on the same date. This transaction is part of his compensation and equity incentive as a board member. The filing indicates direct ownership following the transaction.